Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00527683
Recruitment Status : Completed
First Posted : September 11, 2007
Last Update Posted : April 11, 2008
Catalyst Pharmaceuticals, Inc.
Information provided by:
New York University School of Medicine